Stanford Medicine Cancer Institute
Stanford Medicine Cancer Institute
Stanford, California, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, alveolar soft part sarcoma, connective tissue neoplasm, leiomyosarcoma, myomatous neoplasm, neoplasm, sarcoma, synovial sarcoma | Recruiting | Phase 3 | 2026-02-25 | NCT03016819 |